Tapentadol
Showing 26 - 50 of 89
Chronic Non-cancer Patients Treated With Opioids
Active, not recruiting
- Pain
- +4 more
- (no location specified)
May 3, 2022
Prolonged QTc Interval, Pharmacokinetic Trial in Neuss (100 mg CG5503 (tapentadol HCl) PR tablet, Placebo matching CG5503 PR
Completed
- Prolonged QTc Interval
- Pharmacokinetic
- 100 mg CG5503 (tapentadol hydrochloride) PR tablet
- +3 more
-
Neuss, GermanyDE001 - Contract research organisation
May 15, 2019
Arthroplasty, Replacement, Knee, Nerve Block, Anesthesia, Regional Trial in Ottawa (Normal Saline, Ropivacaine)
Completed
- Arthroplasty, Replacement, Knee
- +3 more
- Normal Saline
- Ropivacaine
-
Ottawa, Ontario, CanadaThe Ottawa Hospital, General Campus
Dec 21, 2020
Adenotonsillar Hypertrophy, Obstructive Sleep Apnea, Sleep-Disordered Breathing Trial in Saint Louis (Ketorolac)
Recruiting
- Adenotonsillar Hypertrophy
- +3 more
-
Saint Louis, MissouriSSM Cardinal Glennon Children's Hospital
Feb 20, 2022
Hypercapnia, Ventilatory Depression Trial in West Bend (Placebo and Oxycodone, Paroxetine and Oxycodone, Escitalopram and
Not yet recruiting
- Hypercapnia
- Ventilatory Depression
- Placebo and Oxycodone
- +2 more
-
West Bend, WisconsinSpaulding Clinical Research
Jul 20, 2022
Pain, Knee Osteoarthritis Trial in Worldwide (Tapentadol ER (100 to 250 mg twice daily), Matching Placebo (twice daily),
Completed
- Pain
- Knee Osteoarthritis
- Tapentadol ER (100 to 250 mg twice daily)
- +2 more
-
Innsbruck, Austria
- +99 more
Oct 7, 2019
Neuropathic Pain Trial in Ciudad de México (Pregabalin 75mg/ Tramadol 50 mg, Pregabalin 75mg)
Not yet recruiting
- Neuropathic Pain
- Pregabalin 75mg/ Tramadol 50 mg
- Pregabalin 75mg
-
Ciudad de México, MexicoLaboratorio Silanes, S.A. de C.V.
Apr 12, 2022
Cognitive Changes With Gabapentin Treatment
Terminated
- Neuralgia Peripheral
- Pain
- Gabapentin
- +5 more
-
Saint Louis, MissouriWashington University Medical Center/Barnes-Jewish Hospital
Feb 24, 2021
Interstitial Cystitis, Painful Bladder Syndrome, Bladder Pain Syndrome Trial in Skokie (low-dose naltrexone, Placebo oral
Recruiting
- Interstitial Cystitis
- +5 more
- low-dose naltrexone
- Placebo oral tablet
-
Skokie, IllinoisCenter for Pelvic Health at the NorthShore University HealthSyst
Apr 4, 2022
Pain Phenotyping of Patients With Bone Cancer Pain
Recruiting
- Pain
- +2 more
-
Copenhagen, Denmark
- +1 more
Mar 1, 2021
Hypercapnia, Ventilatory Depression Trial in West Bend (Oxycodone and Midazolam, Oxycodone, Paroxetine, and Quetiapine)
Completed
- Hypercapnia
- Ventilatory Depression
- Oxycodone and Midazolam
- Oxycodone, Paroxetine, and Quetiapine
-
West Bend, WisconsinSpaulding Clinical Research
Aug 16, 2021
Pain, Chronic Back Pain, Chronic Low Back Pain Trial in United States (Nucynta ER)
Withdrawn
- Pain
- +3 more
- Nucynta ER
-
Jacksonville, Florida
- +6 more
Jan 23, 2018
Techniques in Chronic Low Back Pain inProspective Cohort.
Active, not recruiting
- Low Back Pain
- +4 more
- Fluoroscopically guided lumbar medial branch nerve radiofrequency denervation.
- +5 more
-
Madrid, SpainHospital General Universitario Gregorio Maranon
Aug 23, 2021
Opioid Induced Motor Disturbances Trial in Copenhagen (Tapentadol 50 mg Oral Tablet, Tramadol Hydrochloride 100 mg Extended
Completed
- Opioid Induced Motor Disturbances
- Tapentadol 50 mg Oral Tablet
- +2 more
-
Copenhagen, DenmarkThe Parker Institute, Frederiksberg Hospital
Nov 1, 2017
Pharmacokinetic Trial in Aachen (4 ml CG5503, 5 g charcoal powder)
Completed
- Pharmacokinetic
- 4 ml CG5503
- 5 g charcoal powder
-
Aachen, GermanyDepartment of Clinical Pharmacology Grünenthal GmbH
May 14, 2019
Postoperative Pain in Total Ankle Replacement
Unknown status
- Ankle Osteoarthritis
- Pain, Postoperative
-
Milan, Milano, ItalyIrccs Istituto Ortopedico Galeazzi
Dec 13, 2018
Pain Trial in Japan, Korea, Republic of (Oxycodone CR, R331333 (referred to as JNS024 ER or CG5503))
Completed
- Pain
- Oxycodone CR
- R331333 (referred to as JNS024 ER or CG5503)
-
Chiba, Japan
- +52 more
Jun 22, 2017
Nausea Trial in Toronto (Oxycodone, Hydromorphone)
Completed
- Nausea
-
Toronto, Ontario, CanadaToronto Western Hospital
Nov 22, 2017
Back Pain, Low Back Pain, Neuropathic Pain Trial in Worldwide (Tapentadol Prolonged Release, Oxycodone/Naloxone Prolonged
Completed
- Back Pain
- +2 more
- Tapentadol Prolonged Release
- Oxycodone/Naloxone Prolonged Release
-
Senftenberg, Austria
- +49 more
Jan 25, 2016
Prolonged Release Tapentadol Hydrochloride Among Filipino
Withdrawn
- Moderate to Severe Chronic Non-cancer Pain
- No intervention
- (no location specified)
Nov 30, 2015
Fentanyl, Opioid Use, Surgery Trial in Boston (Fentanyl dose administration)
Unknown status
- Fentanyl
- +3 more
- Fentanyl dose administration
-
Boston, MassachusettsThe Massachusetts General Hospital
Jun 23, 2017
Immediate Release Tapentadol Hydrochloride Among Filipino
Withdrawn
- Moderate to Severe Acute Non-Cancer Pain
- No intervention
- (no location specified)
Sep 25, 2015
Prescribing Behavior of ER/LA Opioid Prescribers
Unknown status
- Opioid Related Disorders
- +3 more
- on-interventional study - retrospective database review
- (no location specified)
Sep 28, 2016